Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1343 of 5804
-
Can a smart app help you save a life? new trial aims to boost CPR quality
Disease control Recruiting nowThe rise in out-of-hospital cardiac arrest (OHCA) cases in Singapore highlights the need for effective bystander cardiopulmonary resuscitation (BCPR). Despite many lay responders performing CPR, survival rates with good neurological outcomes have not significantly improved, promp…
Phase: NA • Sponsor: Singapore General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Glowing poop test could spot rare infant liver disease
Diagnosis Recruiting nowBiliary atresia is a rare, progressive liver disease that only affects infants. It leads to complete obstruction and scarring of the bile duct. Current non-invasive diagnostic tests have limited sensitivity. Indocyanine Green (ICG) is a non-radioactive, fluorescent compound with…
Phase: PHASE1, PHASE2 • Sponsor: Boston Children's Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
New hope for elderly lung cancer patients: combined surgery and rehab study launches
Disease control Recruiting nowThis multicenter prospective clinical study focuses on elderly patients with lung cancer. The investigators will build a standardized clinical registry database, develop perioperative risk stratification and surgical early-warning models, optimize individualized surgical regimens…
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
AI reads scans to pinpoint lung cancer type
Diagnosis Recruiting nowPET/CT imaging and clinical information (age, gender, smoking history, family history of cancer, history of present illness, and several tumor biomarkers, etc.) were used to establish a hierarchical multi-modal AI framework for pathological and genetic subtyping of lung cancer
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
New model helps surgeons choose best operation for rare liver cancer
Knowledge-focused CompletedThe Rboost causal model can identify patients who are most likely to benefit among HCC-BDTT patients. Adherence to the individualized recommendation improves survival. This data-driven tool offers vital support for precision surgical decision-making in this high-risk disease.
Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Triple therapy shrinks head and neck tumors before surgery in early trial
Disease control CompletedThe purpose of this study was to evaluate the safety and tolerability of low-dose radiotherapy plus tislelizumab in combination with afatinib neoadjuvant therapy for patients with surgically resectable squamous carcinoma of the head and neck.
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Probiotics may shield cancer patients from Immunotherapy's gut woes
Prevention TerminatedThe clinical trial tests the use of over-the-counter probiotics VSL#3® 450B in patients receiving immunotherapy. Immunotherapy with monoclonal antibodies, helps the body's immune system attack tumor cells, and interferes with the ability of tumor cells to grow and spread. Immunot…
Phase: NA • Sponsor: Mayo Clinic • Aim: Prevention
Last updated Jun 27, 2026 08:13 UTC
-
Can melatonin or special lights fix long COVID sleep issues?
Symptom relief CompletedThe platform protocol is designed to be flexible so that it is suitable for a range of study settings and intervention types. Therefore, the platform protocol provides a general protocol structure that can be shared by multiple interventions and allows comparative analysis across…
Phase: PHASE2 • Sponsor: Duke University • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
New pill targets Hard-to-Treat cancers with hippo pathway mutations
Disease control Recruiting nowThis is a first-in-human (FIH), Phase 1a/1b open-label, multicenter, dose escalation and dose expansion study of SW-682 in adult participants with metastatic or unresectable advanced solid tumors with or without Hippo pathway alterations that are refractory to, or have progressed…
Phase: PHASE1 • Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Water pill could boost kidney Drug's power and cut side effects
Disease control Recruiting nowAutosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive formation of renal cysts which ultimately lead to a loss of renal function. Tolvaptan (a V2R antagonist) is currently the only effective treatment for preserving renal function in ADPKD. However…
Phase: PHASE3 • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Virtual coach aims to ease chronic pain in veterans
Symptom relief Recruiting nowPain has been identified as among the most frequent presenting medical complaints, in particular within primary care for Veterans. There are few areas of daily living and functioning that pain intensity does not impact, with reported pain intensity related to difficulties in soci…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New stroke drug BB-031 enters human testing
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and tolerability of ascending doses (Part A) and selected doses (Part B) of BB-031 in acute ischemic stroke patients presenting within 24 hours of stroke onset. Participants will be randomized to receive one dose of either the …
Phase: PHASE2 • Sponsor: Basking Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Radioactive 'Smart Bomb' targets Hard-to-Treat cancers in first human test
Disease control OngoingThis is a first-in-human, Phase 1, non-randomized, multicenter, open-label clinical study designed to investigate the safety, tolerability, dosimetry, biodistribution, and pharmacokinetics (PK) of \[225Ac\]-FPI-2068, \[111In\]-FPI-2107, and FPI-2053 in metastatic and/or recurrent…
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New drug could help liver disease patients avoid bleeding during surgery
Disease control OngoingThis study includes Part A and Part B. Part A is a dose-finding study for subjects with chronic liver disease-related thrombocytopenia scheduled for elective surgery. Part B is a multicenter, randomized, double-blind, placebo-controlled Phase III clinical study designed to evalua…
Phase: PHASE3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
French study tracks Ivosidenib's Real-World impact on Hard-to-Treat leukemia
Disease control Recruiting nowMutations in IDH genes are found in numerous cancers and more specifically in acute myeloid leukemia (AML). These mutations target specific amino acids, at positions 140 or 172 of IDH2, and 132 of IDH1. Mutant IDH proteins acquire an abnormal enzymatic activity allowing them to c…
Sponsor: French Innovative Leukemia Organisation • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Period blood may hold key to endometriosis diagnosis
Diagnosis Recruiting nowThe goal of this observational study is to identify diagnostic and prognostic biomarkers for endometriosis using menstrual blood, an easily accessible yet overlooked biological fluid in women of reproductive age, affected or not by endometriosis The main questions it aims to ans…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Diagnosis
Last updated Jun 27, 2026 12:08 UTC
-
New device could spare colon cancer patients from temporary stoma
Disease control CompletedA feasibility study to assess the early safety and effectiveness of the Colovac 2 device in providing temporary protection of the anastomosis in patients undergoing low anterior resection for colon cancer.
Phase: NA • Sponsor: SafeHeal Inc • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can a malaria drug help sarcoidosis patients ditch steroids?
Disease control Recruiting nowSarcoidosis is a systemic granulomatous disease of unknown aetiology, mainly affecting the lungs and lymphatics. It affects people worldwide (incidence, 4.7-64/100000; prevalence, 1-36/100000/year). Although it is most often a benign acute or subacute condition, sarcoidosis may p…
Phase: PHASE4 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 26, 2026 17:09 UTC
-
Could a $4 pill slash stroke risk after brain surgery? new trial aims to find out.
Disease control Recruiting nowAPICES trial is an investigator-initiated, multicenter, multicenter, randomized, double-blind, placebo-controlled clinical trial that plans to enroll 396 patients with a 1-year follow-up, including a neurovascular imaging examination \[digital subtraction angiography (DSA), CT an…
Phase: PHASE4 • Sponsor: Duan Chuanzhi • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Real-world MS drug study tracks relapse reduction in italian patients
Disease control OngoingStudy to evaluate the effectiveness of ofatumumab in Italian RRMS patients in the real-life setting.
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC